These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors. Lauridsen J, Honoré T, Krogsgaard-Larsen P. J Med Chem; 1985 May; 28(5):668-72. PubMed ID: 2859375 [Abstract] [Full Text] [Related]
23. Increasing binding affinity of agonists to glutamate receptors increases synaptic responses at glutamatergic synapses. Shahi K, Baudry M. Proc Natl Acad Sci U S A; 1992 Aug 01; 89(15):6881-5. PubMed ID: 1379724 [Abstract] [Full Text] [Related]
25. Binding of [3H]MK-801, NMDA-displaceable [3H]glutamate, [3H]glycine, [3H]spermidine, [3H]kainate and [3H]AMPA to regionally discrete brain membranes of the gerbil: a biochemical study. Kataoka K, Mitani A, Andou Y, Enomoto R, Ogita K, Yoneda Y. Neurochem Int; 1993 Jan 01; 22(1):37-43. PubMed ID: 7680260 [Abstract] [Full Text] [Related]
30. Phospholipase A2 modulates different subtypes of excitatory amino acid receptors: autoradiographic evidence. Catania MV, Hollingsworth Z, Penney JB, Young AB. J Neurochem; 1993 Jan 01; 60(1):236-45. PubMed ID: 7678040 [Abstract] [Full Text] [Related]
31. Non-NMDA glutamate receptor antagonist 3H-CNOX binds with equal affinity to two agonist states of quisqualate receptors. Honore T, Drejeŕ J, Nielsen EO, Nielsen M. Biochem Pharmacol; 1989 Oct 01; 38(19):3207-12. PubMed ID: 2573355 [Abstract] [Full Text] [Related]
32. NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex. Carlson MD, Penney JB, Young AB. Neurobiol Aging; 1993 Oct 01; 14(4):343-52. PubMed ID: 7690114 [Abstract] [Full Text] [Related]
33. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type. Chalmers DT, Dewar D, Graham DI, Brooks DN, McCulloch J. Proc Natl Acad Sci U S A; 1990 Feb 01; 87(4):1352-6. PubMed ID: 2154742 [Abstract] [Full Text] [Related]
34. 2,4,5-Trihydroxyphenylalanine (6-hydroxy-dopa) displaces [3H]AMPA binding in rat striatum. Cha JH, Dure LS IV, Sakurai SY, Penney JB, Young AB. Neurosci Lett; 1991 Oct 28; 132(1):55-8. PubMed ID: 1664920 [Abstract] [Full Text] [Related]
35. Presynaptic facilitation of dopamine release through D,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors on synaptosomes from the rat striatum. Desce JM, Godeheu G, Galli T, Artaud F, Chéramy A, Glowinski J. J Pharmacol Exp Ther; 1991 Nov 28; 259(2):692-8. PubMed ID: 1682483 [Abstract] [Full Text] [Related]
36. Functional expression of the alpha 1 subunit of the AMPA-selective glutamate receptor channel, using a baculovirus system. Kawamoto S, Onishi H, Hattori S, Miyagi Y, Amaya Y, Mishina M, Okuda K. Biochem Biophys Res Commun; 1991 Dec 16; 181(2):756-63. PubMed ID: 1721809 [Abstract] [Full Text] [Related]
37. Excitatory amino acid receptors and ischemic brain damage in the rat. Westerberg E, Monaghan DT, Cotman CW, Wieloch T. Neurosci Lett; 1987 Jan 14; 73(2):119-24. PubMed ID: 2881232 [Abstract] [Full Text] [Related]
38. Characterization and regional distribution of glutamatergic and cholinergic ligand binding sites in goldfish brain. Henley JM, Oswald RE. J Neurosci; 1988 Jun 14; 8(6):2101-7. PubMed ID: 2898516 [Abstract] [Full Text] [Related]
39. Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states. Hall RA, Massicotte G, Kessler M, Baudry M, Lynch G. Mol Pharmacol; 1993 Mar 14; 43(3):459-64. PubMed ID: 7680752 [Abstract] [Full Text] [Related]
40. Modulation of DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/quisqualate receptors by phospholipase A2 treatment. Massicotte G, Baudry M. Neurosci Lett; 1990 Oct 16; 118(2):245-8. PubMed ID: 2177177 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]